National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
Melissa Parson shares 4 lessons she learned while on assignment with Kaiser Permanente Washington diabetes nurses.
KPWHRI’s Dr. Michael Jackson describes how better testing will improve our ability to forecast the pandemic’s path.
Led by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
From clinical trials to technical support, Dr. Rita Mangione-Smith describes how Kaiser Permanente Washington researchers are fighting the novel coronavirus.
On March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones to follow.